Signal Transduction and Ca^<2+> Signaling in Intact Myocardium
スポンサーリンク
概要
- 論文の詳細を見る
The experimental procedures to simultaneously detect contractile activity and Ca2+ transients by means of the Ca2+ sensitive bioluminescent protein aequorin in multicellular preparations, and the fluorescent dye indo-1 in single myocytes, provide powerful tools to differentiate the regulatory mechanisms of intrinsic and external inotropic interventions in intact cardiac muscle. The regulatory process of cardiac excitation-contraction coupling is classified into three categories; upstream (Ca2+ mobilization), central (Ca2+ binding to troponin C), and/or downstream (thin filament regulation of troponin C property or crossbridge cycling and crossbridge cycling activity itself) mechanisms. While a marked increase in contractile activity by the Frank-Starling mechanism is associated with only a small alteration in Ca2+ transients (downstream mechanism), the force-frequency relationship is primarily due to a frequency-dependent increase of Ca2+ transients (upstream mechanism) in mammalian ventricular myocardium. The characteristics of regulation induced by β- and α-adrenoceptor stimulation are very different between the two mechanisms: the former is associated with a pronounced facilitation of an upstream mechanism, whereas the latter is primarily due to modulation of central and/or downstream mechanisms. α-Adrenoceptor-mediated contractile regulation is mimicked by endothelin ETA- and angiotensin II AT1-receptor stimulation. Acidosis markedly suppresses the regulation induced by Ca2+ mobilizers, but certain Ca2+ sensitizers are able to induce the positive inotropic effect with central and/or downstream mechanisms even under pathophysiological conditions.
- 社団法人 日本薬理学会の論文
- 2006-05-15
著者
-
Endoh Masao
Dep. Of Cardiovascular Pharmacology Yamagata Univ. School Of Medicine Jpn
-
Endoh Masao
Yamagata University
関連論文
- Signal Transduction and Ca^ Signaling in Intact Myocardium
- Ca^ Sensitizers and Congestive Heart Failure(The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Ca^ as potential therapeutic agents for heart failure